To include your compound in the COVID-19 Resource Center, submit it here.

Avita, U.S. Department of Health and Human Services dermatology, gene/cell therapy news

HHS’s Biomedical Advanced Research and Development Authority (BARDA) awarded Avita an $8 million

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE